Use of thiopurines in inflammatory bowel disease

查看全文 作　　者：Pascal [1]Frei;Luc [1]Biedermann;Ole Haagen [2]Nielsen;Gerhard [1]Rogler

机构地区：[1]Division of Gastroenterology and Hepatology,Department of Internal Medicine,University Hospital of Zürich,CH-8091 Zürich,Switzerland;[2]Department of Gastroenterology,Medical Section,Herlev Hospital,University of Copenhagen,DK-2730 Herlev,Denmark

出　　处：《World Journal of Gastroenterology》索引2013年第19卷第7期,共9页

摘　　要：The use of thiopurines as immunosuppression for the treatment of refractory or chronic active inflammatory bowel disease is established for both Crohn's disease and ulcerative colitis.Nevertheless,many questions remain concerning the optimal treatment regimens of azathioprine,6-mercaptopurine and thioguanine.We will briefly summarize dose recommendations,indications for thiopurine therapy and side effects which are relevant in clinical practice.We discuss some currently debated topics,including the combination of azathioprine and allopurinol,switching of thiopurine therapy in case of side effects,the use of azathioprine in pregnancy,the infection risk using thiopurines and the evidence when to stop thiopurines.Excellent reviews have been published on the thiopurine metabolic pathway which will not be discussed here in detail. 关键词：THIOPURINES Inflammatory BOWEL DISEASE Crohn’s DISEASE ULCERATIVE COLITIS IMMUNOSUPPRESSION Infection

相关文献

参考文献（99）
引证文献（4）
耦合文献（6）

参考文献(99)

引证文献(4)

耦合文献(6)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Use of thiopurines in inflammatory bowel disease

参考文献(99)

引证文献(4)

耦合文献(6)

用户提示